Barry Canton is > 10% Shareholder of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 12.4 Million shares of DNA, which is worth approximately $77.1 Million. The most recent transaction as insider was on Dec 19, 2022, when has been sold 206,449 shares (Class A Common Stock) at a price of $1.67 per share, resulting in proceeds of $344,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M
0% 3M change
4.09% 12M change
Total Value Held $77.1 Million

Barry Canton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2022
SELL
Open market or private sale
$344,769 $1.67 p/Share
206,449 Reduced 1.09%
18,802,382 Class A Common Stock
Dec 16 2022
SELL
Open market or private sale
$162,281 $1.6 p/Share
101,426 Reduced 0.53%
19,008,831 Class A Common Stock
Dec 15 2022
SELL
Open market or private sale
$166,710 $1.61 p/Share
103,547 Reduced 0.54%
19,110,257 Class A Common Stock
Dec 14 2022
SELL
Open market or private sale
$172,963 $1.69 p/Share
102,345 Reduced 0.53%
19,213,804 Class A Common Stock
Dec 13 2022
SELL
Open market or private sale
$186,985 $1.89 p/Share
98,934 Reduced 0.51%
19,316,149 Class A Common Stock
Dec 12 2022
SELL
Open market or private sale
$181,435 $1.84 p/Share
98,606 Reduced 0.51%
19,415,083 Class A Common Stock
Dec 09 2022
SELL
Open market or private sale
$179,501 $1.84 p/Share
97,555 Reduced 0.5%
19,513,689 Class A Common Stock
Dec 08 2022
SELL
Open market or private sale
$173,995 $1.79 p/Share
97,204 Reduced 0.49%
19,611,244 Class A Common Stock
Dec 07 2022
SELL
Open market or private sale
$170,536 $1.69 p/Share
100,909 Reduced 0.51%
19,708,448 Class A Common Stock
Dec 06 2022
SELL
Open market or private sale
$178,868 $1.73 p/Share
103,392 Reduced 0.52%
19,809,357 Class A Common Stock
Dec 05 2022
SELL
Open market or private sale
$198,231 $1.87 p/Share
106,006 Reduced 0.53%
19,912,749 Class A Common Stock
Dec 01 2022
SELL
Open market or private sale
$197,845 $1.97 p/Share
100,429 Reduced 0.5%
20,018,755 Class A Common Stock
Nov 30 2022
SELL
Open market or private sale
$183,790 $1.79 p/Share
102,676 Reduced 0.51%
20,119,184 Class A Common Stock
Nov 29 2022
SELL
Open market or private sale
$183,224 $1.9 p/Share
96,434 Reduced 0.47%
20,221,860 Class A Common Stock
Nov 23 2022
SELL
Open market or private sale
$198,596 $1.99 p/Share
99,797 Reduced 0.49%
20,318,294 Class A Common Stock
Nov 22 2022
SELL
Open market or private sale
$207,698 $2.04 p/Share
101,813 Reduced 0.5%
20,418,091 Class A Common Stock
Nov 21 2022
SELL
Open market or private sale
$217,906 $2.1 p/Share
103,765 Reduced 0.5%
20,519,904 Class A Common Stock
Nov 18 2022
SELL
Open market or private sale
$213,879 $2.17 p/Share
98,562 Reduced 0.48%
20,623,669 Class A Common Stock
Nov 17 2022
SELL
Open market or private sale
$460,516 $2.08 p/Share
221,402 Reduced 1.06%
20,722,231 Class A Common Stock
Nov 16 2022
SELL
Open market or private sale
$530,192 $2.42 p/Share
219,088 Reduced 1.04%
20,943,633 Class A Common Stock
Nov 15 2022
SELL
Open market or private sale
$533,231 $2.51 p/Share
212,443 Reduced 0.99%
21,162,721 Class A Common Stock
Nov 14 2022
SELL
Open market or private sale
$567,479 $2.72 p/Share
208,632 Reduced 0.97%
21,375,164 Class A Common Stock
Nov 11 2022
SELL
Open market or private sale
$524,604 $2.65 p/Share
197,964 Reduced 0.91%
21,583,796 Class A Common Stock
Nov 10 2022
SELL
Open market or private sale
$457,628 $2.46 p/Share
186,028 Reduced 0.85%
21,781,760 Class A Common Stock
Nov 09 2022
SELL
Open market or private sale
$505,340 $2.43 p/Share
207,959 Reduced 0.94%
21,967,788 Class A Common Stock
BC

Barry Canton

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA